X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (102) 102
index medicus (99) 99
hematology (81) 81
male (64) 64
female (61) 61
adult (56) 56
middle aged (54) 54
oncology (50) 50
aged (37) 37
transplantation (29) 29
medicine & public health (27) 27
cancer (25) 25
investigating or analysing materials by determining theirchemical or physical properties (23) 23
measuring (23) 23
medical colleges (23) 23
physics (23) 23
testing (23) 23
treatment outcome (23) 23
adolescent (22) 22
chemotherapy (22) 22
leukemia (21) 21
analysis (19) 19
stem cells (19) 19
young adult (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
retrospective studies (18) 18
animals (17) 17
hematopoietic stem cells (16) 16
therapy (16) 16
expression (15) 15
stem-cell transplantation (15) 15
care and treatment (14) 14
immunology (14) 14
multiple myeloma (13) 13
transplantation, homologous (13) 13
chronic myeloid leukemia (12) 12
prognosis (12) 12
bortezomib (11) 11
hematology, oncology and palliative medicine (11) 11
japan (11) 11
medical research (11) 11
medicine, general & internal (11) 11
mice (11) 11
patients (11) 11
recurrence (11) 11
antineoplastic agents - therapeutic use (10) 10
bone-marrow-transplantation (10) 10
chemistry (10) 10
disease-free survival (10) 10
remission (10) 10
research (10) 10
abridged index medicus (9) 9
imatinib (9) 9
medicine, experimental (9) 9
metallurgy (9) 9
organic chemistry (9) 9
peptides (9) 9
remission induction (9) 9
risk factors (9) 9
safety (9) 9
survival (9) 9
blood (8) 8
cell line, tumor (8) 8
diagnosis (8) 8
hemic and lymphatic diseases (8) 8
multiple myeloma - drug therapy (8) 8
mutation (8) 8
rituximab (8) 8
smooth-muscle-cells (8) 8
survival analysis (8) 8
tyrosine (8) 8
acute myeloid-leukemia (7) 7
article (7) 7
cyclophosphamide - administration & dosage (7) 7
disease (7) 7
efficacy (7) 7
endothelial growth-factor (7) 7
follow-up (7) 7
follow-up studies (7) 7
genetic aspects (7) 7
hematopoietic stem cell transplantation - adverse effects (7) 7
hematopoietic stem cell transplantation - methods (7) 7
immunosuppressive agents - therapeutic use (7) 7
ldl-receptor related proteins - blood (7) 7
lr11 (7) 7
lymphoma (7) 7
membrane transport proteins - blood (7) 7
mice, inbred c57bl (7) 7
nilotinib (7) 7
stem cell transplantation (7) 7
transplantation conditioning (7) 7
bone marrow (6) 6
cells (6) 6
chronic disease (6) 6
chronic myelogenous leukemia (6) 6
cyclophosphamide (6) 6
cytarabine - administration & dosage (6) 6
dasatinib (6) 6
disease progression (6) 6
drug therapy (6) 6
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (252) 252
Japanese (17) 17
French (11) 11
German (6) 6
Chinese (2) 2
Korean (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 10/2017, Volume 28, Issue suppl_9
Journal Article
[Rinsho ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 2019, Volume 60, Issue 8, p. 979
POEMS syndrome is a rare paraneoplastic disorder characterized by polyneuropathy, organomegaly, endocrinopathy, λ-type monoclonal protein derived from only two... 
Journal Article
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, ISSN 0021-5384, 07/2016, Volume 105, Issue 7, pp. 1246 - 1254
Journal Article
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, ISSN 0021-5384, 07/2016, Volume 105, Issue 7, p. 1246
Journal Article
Nihon Naika Gakkai Zasshi, ISSN 0021-5384, 2016, Volume 105, Issue 7, pp. 1246 - 1254
Journal Article
[Rinshō ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 10/2014, Volume 55, Issue 10, pp. 2016 - 2026
Journal Article
Annals of Hematology, ISSN 0939-5555, 3/2017, Volume 96, Issue 3, pp. 469 - 478
Journal Article
International Journal of Hematology, ISSN 0925-5710, 11/2018, Volume 108, Issue 5, pp. 491 - 498
Cytoreductive therapy is used in high-risk essential thrombocythemia (ET) to reduce risk of thrombohemorrhagic complications. Anagrelide is an orally active,... 
Essential thrombocythemia | Oncology | Medicine & Public Health | Hematology | Japan | Anagrelide | POLYCYTHEMIA-VERA | EFFICACY | HYDROXYUREA | HYDROXYCARBAMIDE | LEUKEMIA | MATURATION | HEMATOLOGY | Medicine, Experimental | Medical research | Headache | Therapy | Risk groups | Anemia | Complications | Risk reduction | Risk | Titration | Adults | Platelets | Patients | Index Medicus
Journal Article
Journal Article
International Journal of Hematology, ISSN 0925-5710, 9/2017, Volume 106, Issue 3, pp. 398 - 410
Journal Article
International Journal of Hematology, ISSN 0925-5710, 06/2019, Volume 109, Issue 6, p. 633
Byline: Shinsuke Iida (1), Chihiro Shimazaki (2), Masahiro Abe (3), Chiaki Nakaseko (4) Author Affiliation: (1) 0000 0001 0728 1069, grid.260433.0, Department... 
Medical colleges | Multiple myeloma
Journal Article
Journal Article
International Journal of Hematology, ISSN 0925-5710, 06/2019, Volume 109, Issue 6, pp. 633 - 640
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1889 - 1889
Abstract Background Nilotinib (NIL) is a second-generation tyrosine kinase inhibitor (TKI) that exhibits significant efficacy as first- or second-line... 
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 16, pp. 4817 - 4830
Purpose: EZH2 and EZH1, the catalytic components of polycomb repressive complex 2 (PRC2), trigger trimethylation of H3K27 (H3K27me3) to repress the... 
MULTIPLE-MYELOMA | APOPTOSIS | STEM-CELLS | ONCOLOGY | NUCLEAR RECEPTORS | B-CELL LYMPHOMAS | PROSTATE-CANCER | THERAPEUTIC TARGET | GROWTH | ACUTE MYELOID-LEUKEMIA | SOMATIC MUTATIONS | Polycomb Repressive Complex 2 - antagonists & inhibitors | Enhancer of Zeste Homolog 2 Protein - antagonists & inhibitors | Polycomb Repressive Complex 2 - genetics | Humans | Male | Bortezomib - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Pyridones - administration & dosage | Multiple Myeloma - drug therapy | Gene Expression Regulation, Neoplastic - drug effects | Enhancer of Zeste Homolog 2 Protein - genetics | Enhancer of Zeste Homolog 2 Protein - metabolism | Proteasome Inhibitors - pharmacology | Proteasome Inhibitors - administration & dosage | Cells, Cultured | Mice, SCID | Multiple Myeloma - metabolism | Mice, Knockout | Drug Synergism | Xenograft Model Antitumor Assays | Animals | Bortezomib - administration & dosage | Cell Line, Tumor | Mice, Inbred NOD | Proteasome Endopeptidase Complex - metabolism | Polycomb Repressive Complex 2 - metabolism | Multiple Myeloma - genetics | Pyridones - pharmacology | Therapy | Biotechnology | Transcription | Pathogenesis | Multiple myeloma | Myc protein | E2F protein | Xenografts | Catalysis | Inhibition | Sensitizing | Bortezomib | Tumor cell lines | Ribonucleic acid--RNA | Proteasome inhibitors | Polycomb group proteins | Inhibitors | Protease inhibitors | Experimental design | Derepression | Cell lines | Epigenetics | Tumor suppressor genes | Methylation | Prostate cancer | Prostate | Tumors | Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.